IPXHF(IPXHF)
IPXHF
No analyst ratings available
No analyst price targets available for IPXHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.36T | $2.38T | $2.34T | $2.29T | $2.27T |
| Low | $2.07T | $2.07T | $2.04T | $1.99T | $1.98T |
| High | $2.74T | $2.51T | $2.59T | $2.53T | $2.52T |
| EBITDA Avg | $1.62T | $1.63T | $1.61T | $1.57T | $1.56T |
| Low | $1.42T | $1.42T | $1.40T | $1.37T | $1.36T |
| High | $1.88T | $1.72T | $1.78T | $1.73T | $1.72T |
| EBIT Avg | $1.21T | $1.22T | $1.20T | $1.17T | $1.16T |
| Low | $1.06T | $1.06T | $1.05T | $1.02T | $1.02T |
| High | $1.40T | $1.28T | $1.33T | $1.30T | $1.29T |
| Net Income Avg | $487.23B | $505.28B | $491.38B | $471.87B | $529.51B |
| Low | $406.19B | $421.24B | $409.65B | $393.39B | $441.44B |
| High | $554.81B | $575.37B | $559.54B | $537.32B | $602.95B |
| EPS Avg | $408.95 | $424.10 | $412.43 | $396.06 | $444.44 |
| Low | $340.93 | $353.56 | $343.84 | $330.19 | $370.52 |
| High | $465.67 | $482.93 | $469.64 | $451.00 | $506.08 |
| Analysts (Rev / EPS) | 10 / 1 | 11 / 1 | 4 / 1 | 5 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $602.50B | $593.00B |
| Low | $507.31B | $499.31B |
| High | $687.23B | $676.40B |
| EBITDA Avg | $413.06B | $406.55B |
| Low | $347.80B | $342.32B |
| High | $471.16B | $463.72B |
| EBIT Avg | $308.67B | $303.81B |
| Low | $259.91B | $255.81B |
| High | $352.09B | $346.53B |
| Net Income Avg | $117.75B | $139.16B |
| Low | $93.56B | $110.58B |
| High | $139.28B | $164.60B |
| EPS Avg | $93.04 | $109.95 |
| Low | $73.93 | $87.37 |
| High | $110.05 | $130.06 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 |